14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $260.68 $288.54 Wednesday, 24th Apr 2024 AMGN stock ended at $273.01. This is 0.194% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 1.93% from a day low at $269.65 to a day high of $274.86.
90 days $260.68 $329.72
52 weeks $211.73 $329.72

Historical Amgen Inc. prices

Date Open High Low Close Volume
Feb 12, 2024 $289.97 $294.60 $288.86 $294.43 3 295 325
Feb 09, 2024 $294.85 $295.00 $289.72 $291.12 3 340 377
Feb 08, 2024 $297.00 $297.92 $288.78 $294.85 5 943 750
Feb 07, 2024 $315.51 $315.51 $295.28 $295.87 8 321 066
Feb 06, 2024 $325.40 $326.96 $314.75 $316.07 5 729 413
Feb 05, 2024 $323.53 $329.72 $317.72 $321.97 3 553 659
Feb 02, 2024 $323.64 $325.78 $320.75 $323.19 2 536 626
Feb 01, 2024 $314.50 $324.82 $313.70 $324.56 3 521 530
Jan 31, 2024 $316.00 $316.61 $312.62 $314.26 3 228 428
Jan 30, 2024 $312.53 $314.92 $310.52 $314.62 2 598 926
Jan 29, 2024 $311.44 $313.62 $310.00 $313.45 2 182 219
Jan 26, 2024 $310.57 $312.02 $309.86 $311.77 1 935 577
Jan 25, 2024 $308.72 $310.32 $305.70 $310.26 1 911 605
Jan 24, 2024 $309.92 $312.45 $305.27 $305.50 1 949 023
Jan 23, 2024 $309.53 $311.30 $309.10 $309.91 1 768 087
Jan 22, 2024 $308.70 $312.16 $306.60 $310.16 2 238 587
Jan 19, 2024 $304.73 $309.07 $301.11 $307.81 2 348 960
Jan 18, 2024 $302.25 $305.65 $299.55 $304.49 2 030 246
Jan 17, 2024 $302.46 $304.63 $301.25 $304.08 1 833 240
Jan 16, 2024 $306.51 $308.00 $301.18 $303.48 1 816 967
Jan 12, 2024 $305.24 $306.93 $303.42 $306.51 1 536 355
Jan 11, 2024 $303.43 $304.61 $300.00 $303.10 2 119 504
Jan 10, 2024 $307.16 $307.64 $304.28 $304.57 2 070 357
Jan 09, 2024 $308.02 $309.96 $305.94 $307.26 2 584 113
Jan 08, 2024 $301.47 $311.05 $300.37 $310.88 3 450 494
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT